Illumina Inc. (ILMN), whose genetic analysis tools are used in disease research and drug development, accused Life Technologies Corp. (LIFE) of infringing one of its patents. Life Technologies’ Ion Personal Genome Machine and Ion OneTouch System infringe Illumina’s patent for a method of “making and decoding of array sensors with microspheres,” Illumina said in a complaint filed yesterday in federal court in San Diego. The company seeks a court order stopping the alleged infringement and unspecified damages. “Defendants’ infringing acts are willful in that they have knowledge of Illumina’s rights under the ‘431 Patent, but have continued to infringe, and actively induce and contribute to infringement by others,” lawyers for San Diego-based Illumina said in the complaint.
